Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FTN Equity Capital Markets was an investment banking and institutional brokerage firm that operated as a subsidiary of First Horizon National Corporation. The firm provided a range of services including equity research, investment banking, and institutional sales and trading, with a specialized focus on the healthcare and life sciences sectors. It was well-regarded for its deep research coverage of biotechnology and pharmaceutical companies, helping to facilitate capital raises and providing market insights for institutional investors. In 2009, First Horizon sold the institutional equity business of FTN to Sterne Agee Group as part of a strategic restructuring. The firm's legacy in healthcare finance continues through the various analysts and bankers who transitioned to other major financial institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FTN Equity Markets.